{
  "documentMetadata": {
    "title": "Pericarditis, Bacterial",
    "lastUpdated": "2024-04-12",
    "sourceFile": "Pericarditis, Bacterial.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Acute febrile illness with signs and symptoms of pericarditis, with or without tamponade, including fever, chest pain, shortness of breath, signs of elevated venous pressure, tachycardia, hypotension.",
        "Echocardiographic signs of pericardial effusion.",
        "Purulent pericardial fluid.",
        "Recommendations are for empiric therapy while culture and Gram strain results are pending."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "Urgent pericardiocentesis to establish the diagnosis.",
        "Send pericardial fluid for bacterial, fungal and mycobacterial cultures, obtain cultures of blood and send other specimens for culture as clinically indicated."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Staph. aureus (MSSA, MRSA)",
        "Strep. pneumoniae",
        "Streptococci",
        "Neisseria meningitidis",
        "Enterobacteriaceae"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "route": "IV",
            "frequency": "q8-12h"
          },
          {
            "drug": "Ceftriaxone",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q24h",
            "connector": "+"
          },
          {
            "drug": "Cefepime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q12h",
            "connector": "or"
          }
        ],
        "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "as above"
          },
          {
            "drug": "Daptomycin",
            "dose": "10 mg/kg",
            "route": "IV",
            "frequency": "q24h",
            "connector": "or"
          },
          {
            "drug": "Ciprofloxacin",
            "dose": "750 mg",
            "route": "po bid",
            "connector": "+"
          },
          {
            "drug": "Ciprofloxacin",
            "dose": "400 mg",
            "route": "IV bid",
            "connector": "or"
          },
          {
            "drug": "Aztreonam",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q6h",
            "connector": "or"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Empiric use of vancomycin is recommended if local prevalence of MRSA is high; use Nafcillin, Oxacillin, or Cefazolin for confirmed MSSA infection.",
        "Modify regimen and narrow coverage based on results of culture and susceptibility tests."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Drainage required in most cases; immediate drainage indicated if there is evidence of tamponade (see Eur Heart J 34:1186, 2013 for management of pericardial effusion).",
        "Chronic restrictive pericarditis occurs in 20-30% of cases (Curr Opin Cardiol 27:308, 2012); this complication may be prevented by early intrapericardial fibrinolysis (Crit Care 15:220, 2011).",
        "Review article: JAMA 314:1498, 2015.",
        "See Eur Heart J 2015 ; 36:2921 for European guidelines."
      ]
    }
  ]
}
